Table 4.
Repigmentation in the active group for each anatomical site per participant
|
Anatomical site |
|||||
|---|---|---|---|---|---|
| Face/neck | Trunk | Upper limbs | Lower limbs | Hands/feet | |
| Number of participants* |
6 |
6 |
13 |
11 |
3 |
| Repigmentation: | |||||
| Negative–0% |
2 (33%) |
3 (50%) |
3 (22%) |
2 (18%) |
0 |
| 1–24% |
1 (17%) |
2 (33%) |
8 (62%) |
7 (64%) |
2 (67%) |
| 25–49% |
1 (17%) |
0 |
1 (8%) |
2 (18%) |
1 (33%) |
| 50–74% |
0 |
0 |
0 |
0 |
0 |
| 75–100% |
2 (33%) |
1(17%) |
1 (8%) |
0 |
0 |
| Baseline: mean lesion size (cm2 ± SD) |
75.4 ± 7.4 |
13 ± 15.9 |
11.2 ± 10.9 |
21 ± 29.1 |
18.9 ± 25.7 |
| 16 week: mean lesion size (cm2 ± SD) | 47.4 ± 4.4 | 13.7 ± 17.4 | 10.3 ± 9.6 | 20.6 ± 25.8 | 22.6 ± 26.6 |
*One lesion per anatomical site per participant was analysed. If two or more lesions were available on the same anatomical site, the lesion on the right side was chosen. If no lesions were available on the right side, then the lesion, which repigmented the most, was included in the analysis.